259 filings
8-K
DXR
Daxor Corp.
25 Mar 24
Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics
2:00pm
N-CSR/A
DXR
Daxor Corp.
19 Mar 24
Certified annual shareholder report (management investment company) (amended)
5:23pm
N-CEN
DXR
Daxor Corp.
15 Mar 24
Annual report (registered investment company)
5:26pm
N-CSR
DXR
Daxor Corp.
15 Mar 24
Certified annual shareholder report (management investment company)
4:54pm
NT-NCSR/A
DXR
Daxor Corp.
8 Mar 24
Notice of inability to timely file Form N-CSR (amended)
1:49pm
NT-NCSR/A
1wl 0a478n
29 Feb 24
Notice of inability to timely file Form N-CSR (amended)
5:28pm
NT-NCSR
4hc95t4
29 Feb 24
Notice of inability to timely file Form N-CSR
4:15pm
CORRESP
3j43olo71
14 Feb 24
Correspondence with SEC
12:00am
8-K
4t3fqrlqjrb6p t54
2 Jan 24
Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer
8:52am
8-K
vbdh94s60v4q50
27 Nov 23
Other Events
9:12pm
8-K
dqtzm
27 Oct 23
Other Events
5:27pm
N-CSRS
tg60 ucep
28 Aug 23
Certified semi-annual shareholder report (management investment company)
4:01pm
N-PX
k6fb6 gwrmn3
15 Aug 23
Annual report of proxy voting record
7:14am
8-K
7xdt no5c94
13 Jul 23
Submission of Matters to a Vote of Security Holders
4:27pm
8-K
gyz3yj07 nswp2z
25 May 23
Daxor Corporation Announces Closing of $4.0 Million Underwritten Public Offering
7:04pm
N-CEN
3e8zjbf 7tr
16 Mar 23
Annual report (registered investment company)
4:35pm
N-CSR
7vgggrw
1 Mar 23
Certified annual shareholder report (management investment company)
5:11pm
8-K
d5igkjie9b1k
21 Nov 22
Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option
8:12am
N-CSR/A
z6yx 3vcspt
14 Nov 22
Certified annual shareholder report (management investment company) (amended)
4:25pm